{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:17:59Z","timestamp":1776910679082,"version":"3.51.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10554-021-02421-x","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T19:19:27Z","timestamp":1633720767000},"page":"533-542","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of electrocardiography, echocardiography and cardiac T2* for cardiac complications in beta thalassemia major"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3577-188X","authenticated-orcid":false,"given":"Fadime","family":"Ersoy Dursun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8380-3065","authenticated-orcid":false,"given":"G\u00f6n\u00fcl","family":"A\u00e7\u0131ksar\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2176-5278","authenticated-orcid":false,"given":"Ser\u00e7in","family":"\u00d6zk\u00f6k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6335-674X","authenticated-orcid":false,"given":"Onur","family":"\u0130ncealt\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"2421_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","volume":"12","author":"A Cao","year":"2010","unstructured":"Cao A, Galanello R (2010) Beta-thalassemia. Genet Med 12:61\u201376. https:\/\/doi.org\/10.1097\/GIM.0b013e3181cd68ed","journal-title":"Genet Med"},{"key":"2421_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/gim.2016.173","volume":"19","author":"R Origa","year":"2017","unstructured":"Origa R (2017) \u03b2-Thalassemia. Genet Med 19:609\u2013619. https:\/\/doi.org\/10.1038\/gim.2016.173","journal-title":"Genet Med"},{"key":"2421_CR3","first-page":"1187","volume":"89","author":"C Borgna-Pignatti","year":"2004","unstructured":"Borgna-Pignatti C, Rugolotto S, De Stefano P et al (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89:1187\u20131193","journal-title":"Haematologica"},{"key":"2421_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1056\/NEJM199409013310903","volume":"331","author":"NF Olivieri","year":"1994","unstructured":"Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A et al (1994) Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 331:574\u2013578. https:\/\/doi.org\/10.1056\/NEJM199409013310903","journal-title":"N Engl J Med"},{"key":"2421_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCHEARTFAILURE.109.913863","volume":"3","author":"DT Kremastinos","year":"2010","unstructured":"Kremastinos DT, Farmakis D, Aessopos A, Hahalis G, Hamodraka E, Tsiapras D et al (2010) Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives. Circ Heart Fail 3:451\u2013458. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.913863","journal-title":"Circ Heart Fail"},{"key":"2421_CR6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1136\/heartjnl-2012-302857","volume":"99","author":"JM Walker","year":"2013","unstructured":"Walker JM (2013) Thalassaemia major and the heart: a toxic cardiomyopathy tamed? Heart 99:827\u2013834. https:\/\/doi.org\/10.1136\/heartjnl-2012-302857","journal-title":"Heart"},{"key":"2421_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085379","volume":"9","author":"G Yang","year":"2014","unstructured":"Yang G, Liu R, Peng P, Long L, Zhang X, Yang W et al (2014) How early can myocardial iron overload occur in beta thalassemia major? PLoS ONE 9:e85379. https:\/\/doi.org\/10.1371\/journal.pone.0085379","journal-title":"PLoS ONE"},{"key":"2421_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2459\/JCM.0b013e3282f20847","volume":"9","author":"T Cogliandro","year":"2008","unstructured":"Cogliandro T, Derchi G, Mancuso L, Mayer MC, Pannone B, Pepe A et al (2008) Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE). Guideline recommendations for heart complications in thalassemia major. J Cardiovasc Med (Hagerstown) 9:515\u2013525. https:\/\/doi.org\/10.2459\/JCM.0b013e3282f20847","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2421_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-0609.2007.01018.x","volume":"80","author":"A Aessopos","year":"2008","unstructured":"Aessopos A, Berdoukas V, Tsironi M (2008) The heart in transfusion dependent homozygous thalassaemia today\u2014prediction, prevention and management. Eur J Haematol 80:93\u2013106. https:\/\/doi.org\/10.1111\/j.1600-0609.2007.01018.x","journal-title":"Eur J Haematol"},{"key":"2421_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1532-429X-11-20","volume":"11","author":"V Berdoukas","year":"2009","unstructured":"Berdoukas V, Chouliaras G, Moraitis P, Zannikos K, Berdoussi E, Ladis V (2009) The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassemia major: a clinical observational study. J Cardiovasc Magn Reson 11:20. https:\/\/doi.org\/10.1186\/1532-429X-11-20","journal-title":"J Cardiovasc Magn Reson"},{"key":"2421_CR11","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","volume":"22","author":"LJ Anderson","year":"2001","unstructured":"Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH et al (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171\u20132179. https:\/\/doi.org\/10.1053\/euhj.2001.2822","journal-title":"Eur Heart J"},{"key":"2421_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/bjh.12643","volume":"164","author":"C Borgna-Pignatti","year":"2014","unstructured":"Borgna-Pignatti C, Meloni A, Guerrini G, Gulino L, Filosa A, Ruffo GB et al (2014) Myocardial iron overload in thalassaemia major. How early to check? Br J Haematol 164:579\u2013585. https:\/\/doi.org\/10.1111\/bjh.12643","journal-title":"Br J Haematol"},{"key":"2421_CR13","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/bjh.12557","volume":"163","author":"A Pepe","year":"2013","unstructured":"Pepe A, Meloni A, Rossi G, Caruso V, Cuccia L, Spasiano A et al (2013) Cardiac complications and diabetes in thalassaemia major: a large historical multicenter study. Br J Haematol 163:520\u2013527. https:\/\/doi.org\/10.1111\/bjh.12557","journal-title":"Br J Haematol"},{"key":"2421_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/mrm.1910360105","volume":"36","author":"D Li","year":"1996","unstructured":"Li D, Dhawale P, Rubin PJ, Haacke EM, Gropler RJ (1996) Myocardial signal response to dipyridamole and dobutamine: demonstration of the BOLD effect using a double-echogradient-echosequence. Magn Reson Med 36:16\u201320. https:\/\/doi.org\/10.1002\/mrm.1910360105","journal-title":"Magn Reson Med"},{"key":"2421_CR15","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/bjh.12517","volume":"163","author":"R Origa","year":"2013","unstructured":"Origa R, Danjou F, Cossa S, Matta G, Bina P, Dess\u00ec C (2013) Impact of heart magnetic resonance imaging on chelation choices, compliance with treatment and risk of heart disease in patients with thalassemia major. Br J Haematol 163:400\u2013403. https:\/\/doi.org\/10.1111\/bjh.12517","journal-title":"Br J Haematol"},{"key":"2421_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/s0002-9343(01)00879-8","volume":"111","author":"DT Kremastinos","year":"2001","unstructured":"Kremastinos DT, Tsetsos GA, Tsiapras DP, Karavolias GK, Ladis VA, Kattamis CA (2001) Heart failure in beta thalassemia: a 5-year follow-upstudy. Am J Med 111:349\u2013354. https:\/\/doi.org\/10.1016\/s0002-9343(01)00879-8","journal-title":"Am J Med"},{"key":"2421_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.pcad.2011.07.004","volume":"54","author":"LJ Anderson","year":"2011","unstructured":"Anderson LJ (2011) Assessement of iron overload with T2* magnetic resonance imaging. Prog Cardiovasc Dis 54:287\u2013294. https:\/\/doi.org\/10.1016\/j.pcad.2011.07.004","journal-title":"Prog Cardiovasc Dis"},{"key":"2421_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1542-474x.1997.tb00325.x","volume":"2","author":"HC Bazett","year":"2006","unstructured":"Bazett HC (2006) An analysis of the time relationships of electrocardiograms. Ann Noninvasive Electrocardiol 2:177\u2013194. https:\/\/doi.org\/10.1111\/j.1542-474x.1997.tb00325.x","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2421_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1-39.e14. https:\/\/doi.org\/10.1016\/j.echo.2014.10.003","journal-title":"J Am Soc Echocardiogr"},{"key":"2421_CR20","first-page":"271","volume":"8","author":"N Skordis","year":"2011","unstructured":"Skordis N, Kyriakou A (2011) The multifactorial origin of growth failure in thalassaemia. Pediatr Endocrinol Rev 8:271\u2013277","journal-title":"Pediatr Endocrinol Rev"},{"key":"2421_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1515\/jpem.1997.10.2.175","volume":"10","author":"LC Low","year":"1997","unstructured":"Low LC (1997) Growth, puberty and endocrine function in beta-thalassaemia major. J Pediatr Endocrinol Metab 10:175\u2013184. https:\/\/doi.org\/10.1515\/jpem.1997.10.2.175","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2421_CR22","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00277-019-03618-w","volume":"98","author":"F Koohi","year":"2019","unstructured":"Koohi F, Kazemi T, Miri-Moghaddam E (2019) Cardiac complications and iron overload in beta thalassemia major patients\u2014a systematic review and meta-analysis. Ann Hematol 98:1323\u20131331. https:\/\/doi.org\/10.1007\/s00277-019-03618-w","journal-title":"Ann Hematol"},{"key":"2421_CR23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/MPH.0000000000001786","volume":"42","author":"M El-Shanshory","year":"2020","unstructured":"El-Shanshory M, Tolba O, El-Shafiey R, Elgamasy M, Hablas N, Mawlana W (2020) Cardiac iron overload by MRI in children with B-thalassemia major and its correlation with cardiac function by echocardiography. Pediatr Hematol Oncol 42:398\u2013402. https:\/\/doi.org\/10.1097\/MPH.0000000000001786","journal-title":"Pediatr Hematol Oncol"},{"key":"2421_CR24","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.1002\/clc.20310","volume":"32","author":"AK Kondur","year":"2009","unstructured":"Kondur AK, Li T, Vaitkevicius P, Afonso L (2009) Quantification of myocardial iron overload by cardiovascular magnetic resonance imaging T2* and review of the literature. Clin Cardiol 32:E55\u2013E59. https:\/\/doi.org\/10.1002\/clc.20310","journal-title":"Clin Cardiol"},{"key":"2421_CR25","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.2174\/1389450119666180605112235","volume":"19","author":"M Kobayashi","year":"2018","unstructured":"Kobayashi M, Suhara T, Baba Y, Kawasaki NK, Higa JK, Matsui T (2018) Pathological roles of iron in cardiovascular disease. Curr Drug Targets 19:1068\u20131076. https:\/\/doi.org\/10.2174\/1389450119666180605112235","journal-title":"Curr Drug Targets"},{"key":"2421_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/03630269.2018.1488724","volume":"42","author":"U Barbero","year":"2018","unstructured":"Barbero U, Fornari F, Guarguagli S, Gaglioti CM, Longo F, Doronzo B et al (2018) Atrial fibrillation in \u03b2-thalassemia major patients: diagnosis, management and therapeutic options. Hemoglobin 42:189\u2013193. https:\/\/doi.org\/10.1080\/03630269.2018.1488724","journal-title":"Hemoglobin"},{"key":"2421_CR27","doi-asserted-by":"publisher","first-page":"12249","DOI":"10.1002\/jcp.27968","volume":"234","author":"H Nomani","year":"2019","unstructured":"Nomani H, Bayat G, Sahebkar A, Fazelifar AF, Vakilian F, Jomezade V et al (2019) Atrial fibrillation in \u03b2-thalassemia patients with a focus on the role of iron-overload and oxidative stress: a review. J Cell Physiol 234:12249\u201312266. https:\/\/doi.org\/10.1002\/jcp.27968","journal-title":"J Cell Physiol"},{"key":"2421_CR28","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s12185-011-0801-3","volume":"93","author":"V Russo","year":"2011","unstructured":"Russo V, Rago A, Pannone B, Di Meo F, Papa AA, Mayer MC et al (2011) Early electrocardiographic evaluation of atrial fibrillation risk in beta-thalassemia major patients. Int J Hematol 93:446\u2013451. https:\/\/doi.org\/10.1007\/s12185-011-0801-3","journal-title":"Int J Hematol"},{"key":"2421_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0972-6292(16)30753-7","volume":"14","author":"V Russo","year":"2014","unstructured":"Russo V, Rago A, Pannone B, Papa AA, Mayer MC, Spasiano A (2014) Atrial fibrillation and beta thalassemia major: the predictive role of the 12-lead electrocardiogram analysis. Indian Pacing Electrophysiol J 14:121\u2013132. https:\/\/doi.org\/10.1016\/s0972-6292(16)30753-7","journal-title":"Indian Pacing Electrophysiol J"},{"key":"2421_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10840-016-0201-y","volume":"48","author":"A Rago","year":"2017","unstructured":"Rago A, Russo V, Papa AA, Ciardiello C, Pannone B, Mayer MC et al (2017) The role of the atrial electromechanical delay in predicting atrial fibrillation in beta-thalassemia major patients. J Interv Card Electrophysiol 48:147\u2013157. https:\/\/doi.org\/10.1007\/s10840-016-0201-y","journal-title":"J Interv Card Electrophysiol"},{"key":"2421_CR31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s00399-015-0385-3","volume":"26","author":"A Baranchuk","year":"2015","unstructured":"Baranchuk A, Bay\u00e9s de Luna A (2015) The P-wave morphology: what does it tell us? Herzschrittmacherther Elektrophysiol 26:192\u2013199. https:\/\/doi.org\/10.1007\/s00399-015-0385-3","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"2421_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ajh.22205","volume":"87","author":"J Detterich","year":"2012","unstructured":"Detterich J, Noetzli L, Dorey F, Bar-Cohen Y, Harmatz P, Coates T et al (2012) Electrocardiographic consequences of cardiac iron overload in thalassemia major. Am J Hematol 87:139\u2013144. https:\/\/doi.org\/10.1002\/ajh.22205","journal-title":"Am J Hematol"},{"key":"2421_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/MPH.0000000000000467","volume":"38","author":"AA Hamed","year":"2016","unstructured":"Hamed AA, Elguindy W, Elhenawy YI, Ibrahim RH (2016) Early cardiac involvement and risk factors for the development of arrhythmia in patients with beta-thalassemia major. J Pediatr Hematol Oncol 38:5\u201311. https:\/\/doi.org\/10.1097\/MPH.0000000000000467","journal-title":"J Pediatr Hematol Oncol"},{"key":"2421_CR34","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1532\/ijh97.e0407","volume":"80","author":"C Chrysohoou","year":"2004","unstructured":"Chrysohoou C, Panagiotakos DB, Barbetseas Y, Brilli S, Lambrou S, Karagiorga M et al (2004) Echocardiographic and electrocardiographic prognostic factors of heart failure in young patients with beta-thalassemia major: a 10-year (1995\u20132004) follow-up. Int J Hematol 80:336\u2013340. https:\/\/doi.org\/10.1532\/ijh97.e0407","journal-title":"Int J Hematol"},{"key":"2421_CR35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.5152\/akd.2014.5188","volume":"15","author":"N Bayar","year":"2015","unstructured":"Bayar N, Kurto\u011flu E, Arslan \u015e, Erkal Z, \u00c7ay S, \u00c7a\u011f\u0131rc\u0131 G et al (2015) Assessment of the relationship between fragmented QRS and cardiac iron overload in patients with beta-thalassemia major. Anatol J Cardiol 15:132\u2013136. https:\/\/doi.org\/10.5152\/akd.2014.5188","journal-title":"Anatol J Cardiol"},{"key":"2421_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1590\/s0066-782x2013005000001","volume":"100","author":"A Rodrigues","year":"2013","unstructured":"Rodrigues A, Guimar\u00e3es-Filho FV, Braga JC, Rodrigues CS, Waib P, Fabron-Junior A et al (2013) Echocardiography in thalassemic patients on blood transfusions and chelation without heart failure. Arq Bras Cardiol 100:75\u201381. https:\/\/doi.org\/10.1590\/s0066-782x2013005000001","journal-title":"Arq Bras Cardiol"},{"key":"2421_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/03630269.2018.1451341","volume":"42","author":"L Mancuso","year":"2018","unstructured":"Mancuso L, Vitrano A, Mancuso A, Sacco M, Ledda A, Maggio A (2018) left ventricular diastolic dysfunction in beta-thalassemia major with heart failure. Hemoglobin 42:68\u201371. https:\/\/doi.org\/10.1080\/03630269.2018.1451341","journal-title":"Hemoglobin"},{"key":"2421_CR38","first-page":"254","volume":"16","author":"M Barzin","year":"2012","unstructured":"Barzin M, Kowsarian M, Akhlaghpoor S, Jalalian R, Taremi M (2012) Correlation of cardiac MRI T2* with echocardiography in thalassemia major. Eur Rev Med Pharmacol Sci 16:254\u2013260","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2421_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4137\/cmc.s4472","volume":"4","author":"TS Garadah","year":"2010","unstructured":"Garadah TS, Kassab S, Mahdi N, Abu-Taleb A, Jamsheer A (2010) QTc interval and QT dispersion in patients with thalassemia major: electrocardiographic (EKG) and echocardiographic evaluation. Clin Med Insights Cardiol 4:31\u201337. https:\/\/doi.org\/10.4137\/cmc.s4472","journal-title":"Clin Med Insights Cardiol"},{"key":"2421_CR40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1600-0609.2007.00921.x","volume":"79","author":"D Magr\u00ec","year":"2007","unstructured":"Magr\u00ec D, Sciomer S, Fedele F, Gualdi G, Casciani E, Pugliese P et al (2007) Increased QT variability in young asymptomatic patients with beta-thalassemia major. Eur J Haematol 79:322\u2013329. https:\/\/doi.org\/10.1111\/j.1600-0609.2007.00921.x","journal-title":"Eur J Haematol"},{"key":"2421_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.6515\/acs20150824a","volume":"32","author":"IO Yuksel","year":"2016","unstructured":"Yuksel IO, Koklu E, Kurtoglu E, Arslan S, Cagirci G, Karakus V et al (2016) The association between serum ferritin level, tissue doppler echocardiography, cardiac. T2* MRI, and heart rate recovery in patients with beta thalassemia major. Acta Cardiol Sin 32:231\u2013238. https:\/\/doi.org\/10.6515\/acs20150824a","journal-title":"Acta Cardiol Sin"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-021-02421-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-021-02421-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-021-02421-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T08:18:29Z","timestamp":1647418709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-021-02421-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2421"],"URL":"https:\/\/doi.org\/10.1007\/s10554-021-02421-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-657718\/v1","asserted-by":"object"}]},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"value":"1569-5794","type":"print"},{"value":"1573-0743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]},"assertion":[{"value":"25 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the local ethics committee of Medeniyet University Faculty of Medicine prior onset of the study (no:2021\/0257).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent for the study was obtained from each participant after a data-oriented explanation was made about the aims and scope of the study in accordance with the principles of the World Medical Association Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}